FDA Committee Recommends Approval of Lofexidine for Opioid Withdrawal

In a nearly unanimous vote, an FDA committee recently recommended approval of lofexidine (Lucemyra, US WorldMeds), a nonopioid drug designed to relieve symptoms of opioid withdrawal and prevent discontinuation of opioid withdrawal treatment.